血清M30水平可以用作性结肠炎患者的激活标志物吗?
Omer Burcak Binicier1, Sevil Ozer Sarı1, Zehra Betul Pakoz2
1University of Health Sciences Turkey, Izmir Faculty of Medicine, Department of Gastroenterology - İzmir, Turkey.
Revista da Associacao Medica Brasileira (1992)
|September 18, 2024
概括
在性结肠炎 (UC) 患者中,血清M30水平并不是显著的激活标志物. 这一发现表明,M30不是评估UC疾病活性的合适生物标志物,与C反应蛋白和平均血小板体积不同.
科学领域:
- 胃肠病学 胃肠病学
- 生物标志物研究 生物标志物研究
- 炎症性肠道疾病 炎症性肠病
背景情况:
- 疾病激活评估对于性结肠炎 (UC) 治疗决策至关重要.
- 患有UC的患者表现出亡的增加,这表明与细胞死亡相关的潜在生物标志物.
- 在UC中确定可靠的激活标志物仍然是一个临床挑战.
研究的目的:
- 为了评估细胞克拉M30片段的血清水平18.
- 确定M30作为UC患者激活标记物的实用性.
- 为了比较M30水平与已建立的标记物,如C-反应蛋白和平均血小板体积.
主要方法:
- 该研究包括60名UC患者 (30名活跃,30名缓解) 和29名健康对照.
- 测量了血清M30,C反应蛋白和平均血小板体积.
- 在UC患者和对照组之间进行了比较,并在活跃组和缓解组之间进行了比较.
主要成果:
- M30水平显示了积极UC与缓解 (p=0.085) 增加的非显著趋势.
- M30水平与C反应蛋白,平均血小板体积或梅奥评分没有显著相关.
- 根据疾病发生地点,C-反应蛋白和平均血小板体积显示出显著差异.
结论:
- 在UC患者中,M30水平似乎不是显著的激活标志物.
- 与C反应性蛋白和平均血小板体积不同,M30不太可能成为UC疾病活动的有用生物标志物.
- 可能需要进一步的研究来验证UC的其他潜在生物标志物.
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
129
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
129
01:30Serum Laboratory Studies, Stool Test, Breath Test
318
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
318
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
96
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
96
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
151
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
151
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323